TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cryosite Limited ( (AU:CTE) ) has shared an update.
Cryosite Limited has announced its Annual General Meeting of Shareholders, scheduled for October 16, 2025, in Melbourne. The meeting notice is available electronically, and shareholders are encouraged to contact the share registry for further communications. This announcement highlights Cryosite’s commitment to maintaining transparency and engagement with its stakeholders, potentially impacting its operational strategies and industry positioning.
The most recent analyst rating on (AU:CTE) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Cryosite Limited stock, see the AU:CTE Stock Forecast page.
More about Cryosite Limited
Cryosite is an Australian company specializing in outsourced clinical trials depot services. Established in 2000, it provides logistics for clinical trials, including importation, storage, distribution, and reverse logistics for temperature-sensitive products. The company prides itself on its professional, reliable, and compliant services, with a team of highly qualified scientists and clinical trials experts.
Average Trading Volume: 8,504
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$41.98M
See more insights into CTE stock on TipRanks’ Stock Analysis page.